These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 29601674)
1. RFX1 participates in doxorubicin-induced hepatitis B virus reactivation. Wang J; Jia J; Chen R; Ding S; Xu Q; Zhang T; Chen X; Liu S; Lu F Cancer Med; 2018 May; 7(5):2021-2033. PubMed ID: 29601674 [TBL] [Abstract][Full Text] [Related]
2. Doxorubicin Activates Hepatitis B Virus Replication by Elevation of p21 (Waf1/Cip1) and C/EBPα Expression. Chen YF; Chong CL; Wu YC; Wang YL; Tsai KN; Kuo TM; Hong MH; Hu CP; Chen ML; Chou YC; Chang C PLoS One; 2015; 10(6):e0131743. PubMed ID: 26121644 [TBL] [Abstract][Full Text] [Related]
3. Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy. Hsu CH; Hsu HC; Chen HL; Gao M; Yeh PY; Chen PJ; Cheng AL Anticancer Res; 2004; 24(5A):3035-40. PubMed ID: 15517913 [TBL] [Abstract][Full Text] [Related]
4. S-phase arrest after vincristine treatment may promote hepatitis B virus replication. Xu L; Tu Z; Xu G; Hu JL; Cai XF; Zhan XX; Wang YW; Huang Y; Chen J; Huang AL World J Gastroenterol; 2015 Feb; 21(5):1498-509. PubMed ID: 25663769 [TBL] [Abstract][Full Text] [Related]
5. Epirubicin directly promotes hepatitis B virus (HBV) replication in stable HBV-expressing cell lines: a novel mechanism of HBV reactivation following anticancer chemotherapy. Xu L; Tu Z; Xu G; Wang Y; Pan W; Zhan X; Luo Q; Huang Y; Chen J; Huang A Mol Med Rep; 2014 Apr; 9(4):1345-50. PubMed ID: 24566498 [TBL] [Abstract][Full Text] [Related]
6. Cisplatin induces autophagy to enhance hepatitis B virus replication via activation of ROS/JNK and inhibition of the Akt/mTOR pathway. Chen X; Hu Y; Zhang W; Chen K; Hu J; Li X; Liang L; Cai X; Hu J; Wang K; Huang A; Tang N Free Radic Biol Med; 2019 Feb; 131():225-236. PubMed ID: 30550853 [TBL] [Abstract][Full Text] [Related]
7. The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity. Li MS; Lau TC; Chan SK; Wong CH; Ng PK; Sung JJ; Chan HL; Tsui SK PLoS One; 2011; 6(7):e21856. PubMed ID: 21814558 [TBL] [Abstract][Full Text] [Related]
8. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study. Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883 [TBL] [Abstract][Full Text] [Related]
9. Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy. Rossi G; Pelizzari A; Motta M; Puoti M Br J Haematol; 2001 Oct; 115(1):58-62. PubMed ID: 11722410 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy. Hayashi K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Tachi Y; Ishikawa T; Katano Y; Yoshioka K; Toyoda H; Kumada T; Goto H; Hirooka Y J Gastroenterol; 2016 Nov; 51(11):1081-1089. PubMed ID: 26943169 [TBL] [Abstract][Full Text] [Related]
11. Interactions of the transcription factors MIBP1 and RFX1 with the EP element of the hepatitis B virus enhancer. Blake M; Niklinski J; Zajac-Kaye M J Virol; 1996 Sep; 70(9):6060-6. PubMed ID: 8709229 [TBL] [Abstract][Full Text] [Related]
12. Mitomycin, 5-fluorouracil, leflunomide, and mycophenolic acid directly promote hepatitis B virus replication and expression in vitro. Ruan J; Sun S; Cheng X; Han P; Zhang Y; Sun D Virol J; 2020 Jul; 17(1):89. PubMed ID: 32611423 [TBL] [Abstract][Full Text] [Related]
13. Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine. Simpson ND; Simpson PW; Ahmed AM; Nguyen MH; Garcia G; Keeffe EB; Ahmed A J Clin Gastroenterol; 2003 Jul; 37(1):68-71. PubMed ID: 12811213 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role. Steinberg JL; Yeo W; Zhong S; Chan JY; Tam JS; Chan PK; Leung NW; Johnson PJ J Med Virol; 2000 Mar; 60(3):249-55. PubMed ID: 10630955 [TBL] [Abstract][Full Text] [Related]
15. Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy. Yeo W; Steinberg JL; Tam JS; Chan PK; Leung NW; Lam KC; Mok TS; Johnson PJ J Med Virol; 1999 Nov; 59(3):263-9. PubMed ID: 10502254 [TBL] [Abstract][Full Text] [Related]
16. Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy. Niitsu N; Hagiwara Y; Tanae K; Kohri M; Takahashi N J Clin Oncol; 2010 Dec; 28(34):5097-100. PubMed ID: 20837949 [TBL] [Abstract][Full Text] [Related]
17. RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer. Siegrist CA; Durand B; Emery P; David E; Hearing P; Mach B; Reith W Mol Cell Biol; 1993 Oct; 13(10):6375-84. PubMed ID: 8413236 [TBL] [Abstract][Full Text] [Related]
18. ATM and ATR Expression Potentiates HBV Replication and Contributes to Reactivation of HBV Infection upon DNA Damage. Kostyusheva A; Brezgin S; Bayurova E; Gordeychuk I; Isaguliants M; Goptar I; Urusov F; Nikiforova A; Volchkova E; Kostyushev D; Chulanov V Viruses; 2019 Oct; 11(11):. PubMed ID: 31683589 [TBL] [Abstract][Full Text] [Related]
19. Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy. Manzano-Alonso ML; Castellano-Tortajada G World J Gastroenterol; 2011 Mar; 17(12):1531-7. PubMed ID: 21472116 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]